Breast Cancer Flashcards
What is the pathophysiology of breast cancer?
Cancer of the breast begins as a single transformed cell that grows and multiplies in the epithelial cells lining one or more of the mammary ducts or lobules. It is a heterogeneous disease, having many forms with different clinical signs and symptoms, and varying responses to therapy. Some breast cancers present as a palpable lump in the breast, whereas others show up only on a mammogram.
- There are two broad categories of breast cancer: noninvasive and invasive. As long as the cancer remains within the mammary duct, it is referred to as noninvasive. The more common type of breast cancer is classified as invasive; this type grows into surrounding breast tissue.
What are the common sites of breast cancer metastasis?
The most common sites of metastasis are brain, bones, liver, and lung, but breast cancer can spread to any organ.
What are the types of noninvasive (in situ) breast cancers?
- Ductal carcinoma in situ (DCIS) is an early noninvasive form of breast cancer. In DCIS, cancer cells are located within the duct and have not invaded the surrounding fatty breast tissue. Because of more precise mammography screening and earlier detection, the number of women diagnosed with DCIS has increased. Currently there is no way to determine which DCIS lesions will progress to invasive cancer and which ones will remain unchanged; however, evidence does confirm that DCIS can be a precursor to invasive cancer.
- Lobular carcinoma in situ (LCIS) the cells look like cancer cells and are contained within the lobules (milk-producing glands) of the breast. LCIS is not considered cancer but does increase the patient’s risk for developing invasive breast cancer. It is usually diagnosed before menopause in women 40 to 50 years of age. Traditionally LCIS is treated with close observation only, but surgical excision is an option.
What are invasive types of breast cancer?
- Invasive ductal carcinoma. As the name implies, the disease originates in the mammary ducts and breaks through the walls of the ducts into the surrounding breast tissue. Once invasive, the cancer grows into the tissue around it in an irregular pattern. If a lump is present, it is felt as an irregular, poorly defined mass. As the tumor continues to grow, fibrosis (replacement of normal cells with connective tissue and collagen) develops around the cancer. This fibrosis may cause shortening of the Cooper ligaments and the resulting typical skin dimpling that is seen with more advanced disease. Another sign, sometimes indicating late-stage breast cancer, is an edematous thickening and pitting of breast skin called peau d’orange (orange peel skin).
- Inflammatory breast cancer (IBC). It is characterized by diffuse erythema and edema (peau d’orange). Patients typically report breast pain or a rapidly growing breast lump. Other common symptoms include a tender, firm, enlarged breast and breast itching. Because of its aggressive nature, IBC is usually diagnosed at a later stage than other types of breast cancer and is often harder to treat successfully.
What are other types of breast cancer?
Paget Disease
- Paget disease of the nipple is a rare breast cancer that occurs in or around the nipple. Although more common in women, it can also occur in men. It usually affects the nipple ducts, followed by the nipple surface, and then the areola, leaving the area scaly, red, and irritated. It is critical to teach patients to see their health care provider if they have these symptoms, as people with Paget disease often have other types of breast cancer.
Triple-Negative Breast Cancer
- Triple-negative breast cancer (TNBC) lacks expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). This type of breast cancer grows rapidly and is often found in women with BRCA mutation who are premenopausal. African-American women are at higher risk for TNBC than women of other races.
What risk factors are associated with breast cancer?
- Female gender
- Age >65 years old
- Genetic factors: Inherited BRCA1 and/or BRCA2 increases risk
- History of a previous breast cancer
- Breast density: Dense breasts contain more glandular and connective tissue, which increases the risk for developing breast cancer.
- Atypical hyperplasia
- Family history
- Exposure to ionizing radiation
- High postmenopausal bone density: High estrogen levels over time both strengthen bone and increase breast cancer risk.
- Childless women have an increased risk, as do women who bear their first child at or after age 30.
- Menstrual history
Early menstruation (younger than 11 years) or Late menopause (at or older than 55 years) or Both - Recent oral contraceptive use
- Recent hormone replacement therapy (HRT)
- Obesity
- Alcohol consumption
- High socioeconomic status: Breast cancer incidence is greater in women of higher education and socioeconomic background. This relationship is possibly related to lifestyle differences, such as later age at first birth.
- Jewish heritage: Women of Ashkenazi Jewish heritage have higher incidences of BRCA1 and BRCA2 genetic mutations.
What are some health promotion and maintenance tips the nurse notify the patient about?
Mammography
* Women at average risk of breast cancer begin annual screening mammography at age 45 up to age 54. Women ages 40 to 44 should have the choice to start annual mammograms after the risks and potential benefits have been explained. Women age 55 and older may switch to mammograms every 2 years, or continue annual screening mammograms if they choose to do so. Mammography should continue as long as a woman is in good health and has a life expectancy of at least 10 years
Breast Self-Awareness/Self-Examination
- Data demonstrate that breast self-examination is not a meaningful screening tool for breast cancer (Komen, 2020). However, it is recommended that women increase breast self-awareness by becoming familiar with how their breasts look and feel so that they can report differences or abnormalities.
- Teach a woman that lumps are not necessarily abnormal. For premenopausal women, lumps can come and go with the menstrual cycle. Most lumps that are detected and tested are not malignant.
- Some women may want to practice regular breast self-examination (BSE) as a method for breast self-awareness. BSE should be presented as an option to women beginning in their early 20s. In addition to breast self-awareness, place emphasis on clinical breast examination (CBE) and mammogram for early detection of breast cancer. The combined approach is better than any single test. A woman who chooses to perform BSE should be taught the correct technique and have it reviewed by a health care provider during her CBE.
- Use teaching models of normal and abnormal breasts when teaching BSE. Discuss the proper timing for BSE. Instruct premenopausal women to examine their breasts 1 week after the menstrual period. At this time, hormonal influence on breast tissue is decreased, so fluid retention and tenderness are reduced. Teach women whose breast tissue is no longer influenced by hormonal fluctuations, such as after a total hysterectomy or menopause, to pick a day each month to do BSE, such as the first day of the month. The BSE technique is similar for women and men. The Best Practice for Patient Safety & Quality Care: Performing Breast Self-Examination box describes the procedure for breast self-examination and may be used as a patient resource.
What are some other options for high-risk women?
- Those with a personal history of breast cancer are at risk for developing a recurrence or a new breast cancer. Women with known BRCA1 and/or BRCA2 genetic mutation have a lifetime risk of developing breast cancer by age 70 of about 55% to 60% and 45%, respectively. Women in this category usually practice close surveillance as a prevention option. It is a method of secondary prevention and is used to detect cancer early in the initial stages. In addition to annual mammography and clinical breast examination, high-risk women are recommended to have an annual breast MRI screening. Close surveillance may begin as early as age 30 years, but evidence is limited regarding the best age at which to start screening. For women with a high risk for breast cancer development due to family history such as cancer in a mother or sister, it is recommended that cancer screening begin at the age that is 10 years younger than the age at which the affected cancer patient was initially diagnosed. Encourage high-risk women to discuss their personal preferences for close surveillance with their primary health care providers.
- Other options currently available for reducing a woman’s breast cancer risk are prophylactic mastectomy (preventive surgical removal of one or both breasts), prophylactic ophorectomy (removal of the ovaries), and chemopreventive drugs. Although each option significantly reduces the risk for breast cancer, no option completely eliminates it. Each option has its own risks and potentially serious complications.
- Even though a woman may decide to have a prophylactic mastectomy, there is a small risk that breast cancer will develop in residual breast glandular tissue because no mastectomy reliably removes all mammary tissue. Women must also understand that breast reconstruction after a prophylactic mastectomy is very different from breast augmentation. It is a more complex surgical procedure with a greater potential for complications. The decision to have this type of surgery can be a very difficult one to make. Women may find it helpful to reach out to a breast cancer support organization and talk to someone who has been through a prophylactic mastectomy.
- Women undergoing prophylactic oophorectomy will likely experience menopausal symptoms, although some estrogen remains in body fat tissue. Chemoprevention drugs, such as tamoxifen, reduce breast cancer recurrence but carry other risks such as blood clots and endometrial cancer. Encourage women to carefully consider the benefits and risks of breast cancer risk–reducing options and discuss them with their health care provider.
What questions should the nurse ask the patient regarding their history?
Ask specific information about personal and family histories of breast cancer. In addition to increasing the woman’s own risk, these factors also affect any sisters’ or daughters’ risk and should be part of later counseling.
Ask about the woman’s gynecologic and obstetric (if any) history, including:
- Age at menarche
- Age at menopause
- Symptoms of menopause
- Age at first child’s birth (or nulliparity—having no children)
- Number of children and pregnancies, including miscarriages or terminations
What is included in the physical assessment/signs and symptoms?
- Document any abnormal findings from the clinical breast examination.
- Describe specific information about a breast mass (as described in the Best Practice for Patient Safety & Quality Care: Assessing a Breast Mass box), such as location, using the “face of the clock” method; shape; size; consistency; and whether the mass is mobile or fixed to the surrounding tissue.
- Note any skin change, such as peau d’orange, redness and warmth, nipple retraction, or ulceration, which can indicate advanced disease. - Document the location of any enlargements of axillary and supraclavicular lymph nodes.
- Evaluate for the presence of pain or tenderness in the affected breast.
What is a part of the psychosocial assessment?
- A breast cancer diagnosis is usually an unanticipated event in the life of a woman who feels physically well. It initiates a sudden and distressing transition into a potentially life-threatening illness.
- Feelings of fear, shock, and disbelief are predominant as a woman learns about the disease and faces numerous treatment decisions. Psychological distress is common at cancer diagnosis and at the various transitions of treatment.
- A previous history of mental illness, age, and life circumstances can contribute to increased psychological distress. Encourage expression of feelings, focusing on the human component of care and determine if a referral to a counselor would be helpful.
- There are also multiple community resources available for the person diagnosed with breast cancer. Talking with someone who has been through the experience is particularly helpful in dealing with the emotional aspects of the disease.
- Assess the patient for concerns related to sexuality. Sexual dysfunction affects most breast cancer survivors in some way. Sometimes it is related to the loss of a breast and the threat to one’s femininity, her image of herself, or how she perceives her partner’s response. Lack of libido (sexual desire) related to hormonal changes, psychological distress, and anxiety are commonly experienced by women with breast cancer.
- If the patient does not discuss sexual concerns voluntarily, open the conversation in a nonthreatening, nonjudgmental way. Use resources that provide education about alternative expressions of intimacy and a focus on pleasure rather than performance. Refer the patient and her partner to counseling if appropriate.
What laboratory assessments are involved?
- The diagnosis of breast cancer relies on pathologic examination of tissue from the breast mass. After the diagnosis of cancer is established, laboratory tests, including pathologic study of the lymph nodes, help detect possible metastases.
- Elevated liver enzyme levels indicate possible liver metastases, and increased serum calcium and alkaline phosphatase levels could suggest bone metastases.
What diagnostics/imaging is done?
- Mammography is a sensitive screening tool for breast cancer. The uniqueness of this test results from its ability to reveal preclinical lesions (masses too small to be palpated manually). Most breast centers now use digital mammography, a system that is able to read, file, and transmit mammograms electronically.
- Some women may voice concern about radiation exposure with mammograms. Reassure them that the dose is very small and the risk for harm from radiation is minimal.
- Digital breast tomosynthesis is technology that is similar to mammography but uses three-dimensional images. It is useful in evaluating dense breasts and is more accurate in women younger than 50. In the United States, currently it is covered by Medicare and most other major health insurances. This advanced technology is also available in Canada.
- Ultrasonography of the breast is an additional diagnostic tool used to clarify findings on mammography. If the mammogram reveals a lesion, ultrasonography is helpful in differentiating a fluid-filled cyst from a solid mass. Mammography screening combined with ultrasound may be effective for detecting cancers in women with dense breasts, but currently it is not recommended for routine breast cancer screening as a stand-alone imaging tool.
- MRI is used for screening high-risk women and better examination of suspicious areas found on a mammogram. It is more expensive than mammography. Most insurance companies will cover a portion of the cost if the woman is shown to be at high risk. Although higher-quality images are produced, there is concern about high costs and access to quality breast MRI services for high-risk women. Most major insurances will cover a portion of MRI costs for women shown to be at higher risk
- If the patient has an invasive breast cancer, other imaging tests may be done to rule out metastases. Positron emission tomography (PET) scan, brain MRI, and CT scans of the chest, abdomen, and pelvis can reveal distant metastases.
What are other diagnostics that can be done?
- Although imaging techniques serve as tools for screening and more precise visualization of potential breast cancers, breast biopsy (pathologic examination of the breast tissue) is the only definitive way to diagnose breast cancer. - Tissue samples are analyzed by a pathologist to determine the presence of breast cancer. If breast cancer is identified, it is classified according to the size and type of breast cancer, the histologic grade, and the type of receptors on the cells. These characteristics are used to guide treatment. For example, a small, noninvasive breast cancer may only be treated with lumpectomy and radiation, whereas a larger, aggressive tumor (one with a high histologic grade) may be treated with a mastectomy and chemotherapy, followed by radiation.
- Cancer cells that contain estrogen receptors (ER positive) or progesterone receptors (PR positive) have a better prognosis and usually respond to hormonal therapy. If the type of breast cancer is HER2 positive, or one in which the neu gene is overexpressed, it may be treated successfully with trastuzumab, which is a HER2-positive breast cancer–specific targeted therapy.
- Most women, even those with very small tumors, receive some sort of treatment in addition to surgery for breast cancer. Research has focused on ways to predict clinical outcomes so that low-risk women may avoid unnecessary treatments. Genomic tests, such as Oncotype DX and MammaPrint, have been developed to help predict clinical outcomes by analyzing genes in breast cancer tissue. Some health care providers use this information in addition to the pathologic analysis for guiding treatment decisions. These multigene tests have been shown to be accurate predictors of patient prognosis and response to therapy in breast cancer
What are the collaborative problems for a patient with breast cancer?
- Potential for cancer metastasis due to lack of, or inadequate, treatment
- Potential for impaired coping due to breast cancer diagnosis and treatment
What nonsurgical interventions are associated with breast cancer?
Complementary and integrative health
- Women with breast cancer often cope with distressing symptoms related to the disease itself or the side effects of treatment.
- Common symptoms associated with these treatments include pain, nausea/vomiting, hot flashes, anxiety, depression, and fatigue. Physical and emotional symptoms associated with breast cancer may be eased with the use of complementary and integrative therapy. Prayer is also widely used.
- Other types of therapies include guided imagery and massage. The most frequently used strategies are biologically based therapies such as vitamins, special cancer diets, and herbal therapy.
- Teach the patient that all ingested complementary agents potentially risk interaction with conventional drugs.
- Encourage women to seek a practitioner with a certification or license for the specific type of integrative therapy intervention. In some states, a certification or license is required for acupuncture, chiropractic therapy, massage, and shiatsu.
- Some types of complementary and integrative therapy can be self-taught or done alone after a few sessions of instruction.
- Although the use of complementary and integrative therapy can improve quality of life, its use does not alter the outcome of breast cancer, and it should not be used in place of standard treatment. Encourage patients who are interested in trying these therapies to check with their health care provider before using them.
- Cost may be a factor in decision making because not all insurances provide coverage for complementary and integrative therapies. Remind the patient that it is important to disclose to the health care provider all treatments undertaken.
- For patients with breast cancer at a stage for which surgery is the main treatment, follow-up with adjuvant (in addition to surgery) radiation, chemotherapy, hormone therapy, or targeted therapy is commonly prescribed. For those who cannot have surgery or whose cancer is too advanced, these therapies may be used to promote comfort (palliation).
What surgical interventions are associated with breast cancer?
- The patient with breast cancer may appear to have difficulty coping and experience anxiety related to the disease or treatment. The fear and uncertainty for the patient with breast cancer begin the moment a lump is discovered or when a mammogram reveals an abnormality. These feelings may be related to past experiences and personal associations with the disease. Assess the patient’s situational perceptions. Allow the expression of feelings even if a diagnosis has not been established.
- Assess the patient’s need for knowledge. Some may want to read and discuss any available information. Provide accurate information and clarify any misinformation the patient may have received through the media, on the Internet, or from family and friends. If the mass has been diagnosed as cancer, many people feel a partial sense of relief to be dealing with a known entity. A feeling of shock or disbelief usually occurs. It is difficult to accept a diagnosis of cancer when one feels basically well. Patients and their families or significant others deal in individual ways with the mix of feelings. Adjust your approach to care as the patient’s emotional state changes. The goal is to have the patient participate as an active partner in management of the disease.
An integral part of the plan to meet these emotional needs is the use of outside resources. For example, the patient who is worried in particular about the side effects of radiation therapy may benefit more from talking to someone who has undergone radiation than from talking to the nurse or primary health care provider. The American Cancer Society’s “Reach to Recovery” program is just one community resource that connects breast cancer patients to a peer who has lived through the treatment the patient is facing. Be sure to assess her preference and place appropriate referrals. - Another helpful resource for patients who desire to receive care at one location is a full-service cancer center. Some agencies have all cancer services offered comprehensively in one location, including surgeon and provider services, counseling, nursing care, social services, nutrition services, rehabilitation, various therapies (including chemotherapy), and spiritual ministry. Obtaining all services in one familiar location can decrease the stress that the patient feels.